Navigation Links
John Daly, Previous Merck Exec., Starts CTW Consulting Firm
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire-iReach/ -- Former Merck executive, John Daly, recently founded CTW with two primary missions.

(Photo: http://photos.prnewswire.com/prnh/20131202/MN25895)

The first is to offer pharmaceutical industry consulting services to corporations such as IMS Health. Providing strategy for next-generation commercialization solutions focused on integrated and accountable care emerging stakeholders and next-generation sales excellence solutions for the new pharma environment.

In addition, CTW's front-line leadership and coaching mission is to ensure their clients identify and cultivate engaging leadership. Through customer centric coaching, CTW clients empower culture, fuel innovation and the full realization of their vision.

"A great business model, people, commercial opportunity and a defined vision is not enough. Investing in and putting your people first means having purposeful, strategic and effective front-line leaders." said Daly. CTW's Customer Centric Coaching model ingrains four core coaching principles that enable sales leaders to identify, leverage and build upon what motivates individual sales professionals.

Daly's previous employment as director of commercial operations and regional sales director at Schering Plough / Merck has allowed him to fuel hundreds of millions in sales by directing multiple regions and teams in brand sales to primary care, multispecialty, integrated physician groups, and managed care organizations. Daly has also strengthened and led innovative healthcare partnerships, solutions and quality outcome-focused strategies.

To learn more about John Daly and CTW visit http://john-daly-merck.com/

About John Daly

With two decades of experience in the pharmaceutical industry, John Daly has served as a sales leader and director of commercial operations since 2004 with Bayer Healthcare, Schering Plough Corporation and Merck & Co., Inc. based in North Wales, Pennsylvania. He has led the commercial operations of several regions in a number of therapeutic areas including respiratory allergy and asthma, diabetes, neurology and cardiovascular disease. His success has included developing current leaders, brand team partnerships and field leadership of multiple product launches and excellent integration and change leadership. Daly's consistent strong performance as a regional sales director has earned him a number of sales awards and corporate recognitions spanning cross-functional programs and special initiatives.

Media Contact: Deanna Dunsmuir, X Factor Selling Systems, 9736008321, deanna@thesalesexpertusa.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CTW consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe Withdraws from Previously Announced Investor Presentations
2. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
3. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
4. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
5. PDI, Inc. Announces Client FDA Product Approval Related to Previously Disclosed Contract
6. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
7. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
8. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
9. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):